ASND Annual Accounts Payable
$104.53 M
-$3.81 M-3.52%
31 December 2023
Summary:
As of January 23, 2025, ASND annual accounts payable is $104.53 million, with the most recent change of -$3.81 million (-3.52%) on December 31, 2023. During the last 3 years, it has risen by +$77.60 million (+288.13%). ASND annual accounts payable is now -3.52% below its all-time high of $108.35 million, reached on December 31, 2022.ASND Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASND Quarterly Accounts Payable
$84.07 M
-$22.62 M-21.20%
01 September 2024
Summary:
As of January 23, 2025, ASND quarterly accounts payable is $84.07 million, with the most recent change of -$22.62 million (-21.20%) on September 1, 2024. Over the past year, it has dropped by -$44.60 million (-34.66%). ASND quarterly accounts payable is now -41.35% below its all-time high of $143.33 million, reached on March 31, 2023.ASND Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASND Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -34.7% |
| 3 y3 years | +288.1% | -5.2% |
| 5 y5 years | +362.9% | +215.6% |
ASND Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +55.4% | -41.4% | +25.0% |
| 5 y | 5-year | -3.5% | +288.1% | -41.4% | +212.1% |
| alltime | all time | -3.5% | +3105.0% | -41.4% | +2315.8% |
Ascendis Pharma A/S Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $84.07 M(-21.2%) |
| June 2024 | - | $106.68 M(+4.5%) |
| Mar 2024 | - | $102.08 M(-2.3%) |
| Dec 2023 | $104.53 M(-3.5%) | $104.53 M(-18.8%) |
| Sept 2023 | - | $128.66 M(-3.1%) |
| June 2023 | - | $132.71 M(-7.4%) |
| Mar 2023 | - | $143.33 M(+32.3%) |
| Dec 2022 | $108.35 M(+61.1%) | $108.35 M(+28.0%) |
| Sept 2022 | - | $84.63 M(+8.0%) |
| June 2022 | - | $78.33 M(-0.7%) |
| Mar 2022 | - | $78.89 M(+17.3%) |
| Dec 2021 | $67.27 M(+149.8%) | $67.27 M(-24.2%) |
| Sept 2021 | - | $88.70 M(+68.6%) |
| June 2021 | - | $52.61 M(-17.1%) |
| Mar 2021 | - | $63.46 M(+135.6%) |
| Dec 2020 | $26.93 M(-13.4%) | $26.93 M(-39.8%) |
| Sept 2020 | - | $44.74 M(+26.0%) |
| June 2020 | - | $35.51 M(+18.0%) |
| Mar 2020 | - | $30.08 M(-3.3%) |
| Dec 2019 | $31.10 M | $31.10 M(+16.8%) |
| Sept 2019 | - | $26.64 M(+10.3%) |
| June 2019 | - | $24.14 M(+11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $21.60 M(-4.3%) |
| Dec 2018 | $22.58 M(+8.0%) | $22.58 M(-37.4%) |
| Sept 2018 | - | $36.05 M(-14.9%) |
| June 2018 | - | $42.33 M(+97.2%) |
| Mar 2018 | - | $21.47 M(+2.6%) |
| Dec 2017 | $20.92 M(+51.3%) | $20.92 M(-9.4%) |
| Sept 2017 | - | $23.08 M(+29.9%) |
| June 2017 | - | $17.77 M(-4.9%) |
| Mar 2017 | - | $18.69 M(+35.2%) |
| Dec 2016 | $13.83 M(+51.0%) | $13.83 M(+8.1%) |
| Sept 2016 | - | $12.78 M(+13.8%) |
| June 2016 | - | $11.24 M(+18.9%) |
| Mar 2016 | - | $9.45 M(+3.2%) |
| Dec 2015 | $9.15 M(+51.9%) | $9.15 M(+51.0%) |
| Sept 2015 | - | $6.06 M(-22.5%) |
| June 2015 | - | $7.82 M(+32.8%) |
| Mar 2015 | - | $5.89 M(-2.3%) |
| Dec 2014 | $6.03 M(+73.2%) | $6.03 M(+56.0%) |
| Sept 2014 | - | $3.86 M(+11.0%) |
| Dec 2013 | $3.48 M(+3.9%) | $3.48 M |
| Dec 2012 | $3.35 M(+2.7%) | - |
| Dec 2011 | $3.26 M | - |
FAQ
- What is Ascendis Pharma A/S annual accounts payable?
- What is the all time high annual accounts payable for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual accounts payable year-on-year change?
- What is Ascendis Pharma A/S quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly accounts payable year-on-year change?
What is Ascendis Pharma A/S annual accounts payable?
The current annual accounts payable of ASND is $104.53 M
What is the all time high annual accounts payable for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual accounts payable is $108.35 M
What is Ascendis Pharma A/S annual accounts payable year-on-year change?
Over the past year, ASND annual accounts payable has changed by -$3.81 M (-3.52%)
What is Ascendis Pharma A/S quarterly accounts payable?
The current quarterly accounts payable of ASND is $84.07 M
What is the all time high quarterly accounts payable for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly accounts payable is $143.33 M
What is Ascendis Pharma A/S quarterly accounts payable year-on-year change?
Over the past year, ASND quarterly accounts payable has changed by -$44.60 M (-34.66%)